- Home
- NPO vs SRRK Comparison
NPO vs SRRK Comparison
Compare NPO & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPO
- SRRK
- Stock Information
- Founded
- NPO 2002
- SRRK 2012
- Country
- NPO United States
- SRRK United States
- Employees
- NPO N/A
- SRRK N/A
- Industry
- NPO Metal Fabrications
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NPO Industrials
- SRRK Health Care
- Exchange
- NPO Nasdaq
- SRRK Nasdaq
- Market Cap
- NPO 3.9B
- SRRK 3.2B
- IPO Year
- NPO N/A
- SRRK 2018
- Fundamental
- Price
- NPO $204.19
- SRRK $37.44
- Analyst Decision
- NPO Buy
- SRRK Strong Buy
- Analyst Count
- NPO 2
- SRRK 6
- Target Price
- NPO $202.50
- SRRK $42.17
- AVG Volume (30 Days)
- NPO 133.6K
- SRRK 1.4M
- Earning Date
- NPO 08-05-2025
- SRRK 08-07-2025
- Dividend Yield
- NPO 0.61%
- SRRK N/A
- EPS Growth
- NPO N/A
- SRRK N/A
- EPS
- NPO 4.01
- SRRK N/A
- Revenue
- NPO $1,064,400,000.00
- SRRK N/A
- Revenue This Year
- NPO $4.99
- SRRK N/A
- Revenue Next Year
- NPO $5.27
- SRRK $502.60
- P/E Ratio
- NPO $50.72
- SRRK N/A
- Revenue Growth
- NPO 2.92
- SRRK N/A
- 52 Week Low
- NPO $133.50
- SRRK $6.76
- 52 Week High
- NPO $214.58
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- NPO 64.08
- SRRK 59.82
- Support Level
- NPO $198.25
- SRRK $33.60
- Resistance Level
- NPO $207.02
- SRRK $38.15
- Average True Range (ATR)
- NPO 4.47
- SRRK 1.91
- MACD
- NPO 0.59
- SRRK 0.21
- Stochastic Oscillator
- NPO 84.40
- SRRK 89.12
About NPO Enpro Inc.
Enpro Inc formerly EnPro Industries Inc is a United States-based company that designs, develops, manufactures, and markets proprietary engineered industrial products. The company operates through three segments: Sealing Technologies, which derives maximum revenue, manufactures and markets sealing products, wheel-end components & systems; and Advanced Surface Technologies manufactures wafer processing sub-systems, thin-film coatings, optical filters, and other services like cleaning, coating, testing, and refurbishment. Its geographical segments are the United States, Europe, and other foreign countries.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.